Methods to inhibit or augment an inflammatory response

Details Methods to inhibit or augment an inflammatory response Methods to inhibit or augment an inflammatory response

2011-08-02

2011-08-02

Hui, San-ming (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

07989466

ABSTRACT:
Isolated and purified chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs, are provided.

REFERENCES:
patent: 2726243 (1955-12-01), Huebner
patent: 2740788 (1956-04-01), Grussner et al.
patent: 2743270 (1956-04-01), Blicke
patent: 3168565 (1965-02-01), Palopoli et al.
patent: 4108855 (1978-08-01), Mago nee Karacsony et al.
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4737580 (1988-04-01), Twardzik et al.
patent: 4774318 (1988-09-01), Marquardt et al.
patent: 5028594 (1991-07-01), Carson
patent: 5079228 (1992-01-01), Cohen et al.
patent: 5155038 (1992-10-01), Eyal et al.
patent: 5190918 (1993-03-01), Deutch et al.
patent: 5190920 (1993-03-01), Eyal et al.
patent: 5192744 (1993-03-01), Bouck et al.
patent: 5202118 (1993-04-01), Gillis et al.
patent: 5212073 (1993-05-01), Rollins et al.
patent: 5248666 (1993-09-01), Twardzik et al.
patent: 5302384 (1994-04-01), Gimbrone, Jr. et al.
patent: 5357041 (1994-10-01), Roberts et al.
patent: 5401651 (1995-03-01), Walz
patent: 5426100 (1995-06-01), Deutch et al.
patent: 5458874 (1995-10-01), Pereira et al.
patent: 5459128 (1995-10-01), Rollins et al.
patent: 5474983 (1995-12-01), Kuna et al.
patent: 5491130 (1996-02-01), Roberts et al.
patent: 5529904 (1996-06-01), Ginsburg et al.
patent: 5532144 (1996-07-01), Yoshimura et al.
patent: 5545623 (1996-08-01), Matsumori
patent: 5556757 (1996-09-01), Alstyne et al.
patent: 5571713 (1996-11-01), Lyle et al.
patent: 5578714 (1996-11-01), Pogo et al.
patent: 5589458 (1996-12-01), Jameson et al.
patent: 5597578 (1997-01-01), Brown et al.
patent: 5605671 (1997-02-01), Lyle et al.
patent: 5627156 (1997-05-01), Talmadge
patent: 5627265 (1997-05-01), Frazier et al.
patent: 5629327 (1997-05-01), D'Amato
patent: 5645837 (1997-07-01), Jameson et al.
patent: 5646117 (1997-07-01), Matsushima et al.
patent: 5650150 (1997-07-01), Gillies
patent: 5661132 (1997-08-01), Eriksson et al.
patent: 5663294 (1997-09-01), Colman et al.
patent: 5684032 (1997-11-01), Elliott et al.
patent: 5700821 (1997-12-01), Lazo et al.
patent: 5705360 (1998-01-01), Rollins et al.
patent: 5707814 (1998-01-01), Levy et al.
patent: 5707815 (1998-01-01), Charo et al.
patent: 5770609 (1998-06-01), Grainger et al.
patent: 5807482 (1998-09-01), House
patent: 5811449 (1998-09-01), Medford et al.
patent: 5817911 (1998-10-01), Williams et al.
patent: 5824299 (1998-10-01), Luster et al.
patent: 5824551 (1998-10-01), Damme et al.
patent: 5824647 (1998-10-01), Postlethwaite et al.
patent: 5827821 (1998-10-01), Pierschbacher et al.
patent: 5831032 (1998-11-01), Schraufstatter et al.
patent: 5871740 (1999-02-01), Smith
patent: 5877276 (1999-03-01), Talmadge
patent: 5908829 (1999-06-01), Kelly
patent: 5955485 (1999-09-01), De Brabander et al.
patent: 5955492 (1999-09-01), Thompson et al.
patent: 6162455 (2000-12-01), Cleale et al.
patent: 6989435 (2006-01-01), Grainger et al.
patent: 7067117 (2006-06-01), Grainger et al.
patent: 7238711 (2007-07-01), Grainger et al.
patent: 7700087 (2010-04-01), Grainger et al.
patent: 2002/0182650 (2002-12-01), Sworin et al.
patent: 2006/0073114 (2006-04-01), Grainger et al.
patent: 24 36 820 (1975-02-01), None
patent: 2710246 (1977-09-01), None
patent: 0 281 363 (1988-09-01), None
patent: 0 353 772 (1990-02-01), None
patent: 0 373 994 (1990-06-01), None
patent: 0807439 (1997-11-01), None
patent: 0860446 (1998-08-01), None
patent: 0905241 (1999-03-01), None
patent: 2183578 (1973-12-01), None
patent: 2239471 (1975-02-01), None
patent: 1359260 (1974-07-01), None
patent: 1414589 (1975-11-01), None
patent: 2 319 252 (1998-05-01), None
patent: 36-14610 (1961-08-01), None
patent: 06-025288 (1994-02-01), None
patent: 7-67689 (1995-03-01), None
patent: 09255570 (1997-09-01), None
patent: 11124393 (1999-05-01), None
patent: 11127859 (1999-05-01), None
patent: 11128208 (1999-05-01), None
patent: 11130767 (1999-05-01), None
patent: 11130778 (1999-05-01), None
patent: 11130792 (1999-05-01), None
patent: 11137283 (1999-05-01), None
patent: 11137299 (1999-05-01), None
patent: WO-86/04334 (1986-07-01), None
patent: WO-90/07863 (1990-07-01), None
patent: WO-91/03491 (1991-03-01), None
patent: WO-91/08483 (1991-06-01), None
patent: WO-91/17179 (1991-11-01), None
patent: WO-92/04372 (1992-03-01), None
patent: WO-92/14455 (1992-09-01), None
patent: WO-92/20372 (1992-11-01), None
patent: 93/10796 (1993-06-01), None
patent: WO-93/10796 (1993-06-01), None
patent: WO-93/11159 (1993-06-01), None
patent: WO-9310796 (1993-06-01), None
patent: WO-94/11014 (1994-05-01), None
patent: WO-94/20116 (1994-09-01), None
patent: WO-94/20117 (1994-09-01), None
patent: WO-94/20126 (1994-09-01), None
patent: WO-94/20127 (1994-09-01), None
patent: WO-94/20512 (1994-09-01), None
patent: WO-95/05191 (1995-02-01), None
patent: WO-95/17420 (1995-06-01), None
patent: WO-95/17421 (1995-06-01), None
patent: WO-95/20973 (1995-08-01), None
patent: WO-95/26982 (1995-10-01), None
patent: WO-96/20722 (1996-07-01), None
patent: WO-96/22371 (1996-07-01), None
patent: WO-9625157 (1996-08-01), None
patent: WO-96/29074 (1996-09-01), None
patent: WO-97/01350 (1997-01-01), None
patent: WO-97/12615 (1997-04-01), None
patent: WO-97/19173 (1997-05-01), None
patent: WO-97/21812 (1997-06-01), None
patent: WO-97/22698 (1997-06-01), None
patent: WO-97/24325 (1997-07-01), None
patent: WO-97/25427 (1997-07-01), None
patent: WO-97/29192 (1997-08-01), None
patent: WO-97/31098 (1997-08-01), None
patent: WO-97/31949 (1997-09-01), None
patent: WO-97/32019 (1997-09-01), None
patent: WO-97/32993 (1997-09-01), None
patent: WO-97/35010 (1997-09-01), None
patent: WO-97/35982 (1997-10-01), None
patent: WO-97/44462 (1997-11-01), None
patent: WO-97/45543 (1997-12-01), None
patent: WO-98/06703 (1998-02-01), None
patent: WO-98/09171 (1998-03-01), None
patent: WO-98/12324 (1998-03-01), None
patent: WO-98/13495 (1998-04-01), None
patent: WO-98/23750 (1998-06-01), None
patent: WO-98/24808 (1998-06-01), None
patent: 98/42354 (1998-10-01), None
patent: WO-98/42484 (1998-10-01), None
patent: WO-9842354 (1998-10-01), None
patent: WO-98/00535 (1998-12-01), None
patent: WO-98/54326 (1998-12-01), None
patent: WO-99/04770 (1999-02-01), None
patent: WO-99/04791 (1999-02-01), None
patent: WO-99/05279 (1999-02-01), None
patent: WO-99/12968 (1999-03-01), None
patent: WO-99/37617 (1999-07-01), None
patent: WO-99/37619 (1999-07-01), None
patent: WO-99/37651 (1999-07-01), None
patent: WO-99/42461 (1999-08-01), None
patent: WO-99/42463 (1999-08-01), None
patent: WO-00/00821 (2000-01-01), None
patent: WO-00/42071 (2000-07-01), None
patent: WO-02076399 (2002-10-01), None
patent: WO-02094270 (2002-11-01), None
patent: WO-2007042504 (2007-04-01), None
Harrison et al., Am J Respir Crit Care Med, 1999;159:1918-1924.
“Blocking CCR5 Stops M-tropic HIV Infection”,Biotechnology News, 17, (1997),3.
“Developed Adjuvant Polyarthritis Assay in Rats (Therapeutic)”, Product and Services Information, Chrysalis Company, Olyphant, PA,(1997),1 p.
“Developing Adjuvant Polyarthritis Assay in Rats (Prophylactic)”, Product and Services Information, Chrysalis Company, Olyphant, PA,(1997),1 p.
“Leukotrine Antagonists Making Their Mark in Asthma”,SCRIP, No. 2376, John Davis, (ed.),(Oct. 7, 1998),23.
Adkins, J. C., et al., “Zafirlukast—A Review of its Pharmacology and Therapeutic Potential in the Management of Asthma”,Drugs, 55, (1998),121-144.
Albanesi, C. , et al., “Cetirizine and Hydrocortisone Differentially Regulate ICAM-I Expression and Chemokine Release in Cultured Human Keratinocytes”,Clinical and Experimental Allergy, 28(1), (Jan. 1998),101-109.
Albini, A , et al., “Hiv-1 Tat Protein Mimicry of Chemokines”,Proceedings of the National Academy of Sciences USA, 95(22), (Oct. 27, 1998),13153-13158.
Alkhatib, G. , et al., “HIV-1 Coreceptor Activity of CCR5 and Its Inhibition by Chemokines: Independence from G Protein Signaling and Importance of Coreceptor Downmodulation”,Virology, 234(2), (Aug. 4, 1997),340-348.
Amann, B. , et al., “Urinary Levels of Monocyte Chemo-A

Affiliated with

Also associated with

Rating

Methods to inhibit or augment an inflammatory response does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods to inhibit or augment an inflammatory response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods to inhibit or augment an inflammatory response will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2668691